Literature DB >> 14600394

The behavior of dihydropyrazine with DNA strand-breakage activity in vivo.

Tadatoshi Yamaguchi1, Hajime Nomura, Kazuhisa Matsunaga, Shigeru Ito, Jiro Takata, Yoshiharu Karube.   

Abstract

The effects on the viability of cell lines treated with 2,3-dihydro-5,6-dimethylpyrazine and its derivatives, which revealed DNA strand-breakage activity by the generation of radicals in vitro, were recognized from certain morphological changes and the detection of apoptosis-related proteins: cleaved PARP and SAPK/JNK. These results would suggest that sugar-derived dihydropyrazines induce changes in the cells of certain organs and cause various internal injuries in vivo. The biodistribution of 14C-labelled 2,3-dihydro-5,6-dimethylpyrazine was studied in mouse and the autoradiograms showed highly contrasting results. Radioactivity was high in the brain, spinal cord, salivary gland, and thymus and low in the heart, stomach, and blood. The result was supported by the activity (% dose per organ).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600394     DOI: 10.1248/bpb.26.1523

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Preferential DNA cleavage under anaerobic conditions by a DNA-binding ruthenium dimer.

Authors:  Thamara K Janaratne; Abhishek Yadav; Fiona Ongeri; Frederick M MacDonnell
Journal:  Inorg Chem       Date:  2007-03-28       Impact factor: 5.165

2.  2-Methyl-3,5,6-triphenyl-2,3-dihydro-pyrazine.

Authors:  N Anuradha; A Thiruvalluvar; K Pandiarajan; S Chitra; R J Butcher
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-02-18

3.  Cellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands.

Authors:  Cynthia Griffith; Adam S Dayoub; Thamara Jaranatne; Nagham Alatrash; Ali Mohamedi; Kenneth Abayan; Zachary S Breitbach; Daniel W Armstrong; Frederick M MacDonnell
Journal:  Chem Sci       Date:  2017-03-08       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.